ProciseDx has a total of 37 patents globally, out of which 6 have been granted. Of these 37 patents, more than 59% patents are active. United States of America is where ProciseDx has filed the maximum number of patents, followed by Europe and Austria. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of ProciseDx.
ProciseDx was founded in the year 2018. The Company operates as a biopharmaceutical company. The Company focuses on the development of therapeutics and companion diagnostics for inflammatory bowel diseases.
Do read about some of the most popular patents of ProciseDx which have been covered by us in this article and also you can find ProciseDx patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over ProciseDx patent portfolio.
How many patents does ProciseDx have?
ProciseDx has a total of 37 patents globally. These patents belong to 16 unique patent families. Out of 37 patents, 22 patents are active.
How Many Patents did ProciseDx File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | ProciseDx Applications Filed | ProciseDx Patents Granted |
2023 | – | 2 |
2022 | 3 | 1 |
2021 | 9 | 3 |
2020 | 17 | – |
2019 | 5 | – |
2018 | 1 | – |
2017 | 1 | – |
2016 | 1 | – |
How many ProciseDx patents are Alive/Dead?
How Many Patents did ProciseDx File in Different Countries?
Countries in which ProciseDx Filed Patents
Country | Patents |
United States Of America | 15 |
Europe | 11 |
Austria | 1 |
Spain | 1 |
Where are Research Centres of ProciseDx Patents Located?
Best ProciseDx Patents
US20200222896A1 is the most popular patent in the ProciseDx portfolio. It has received 3 citations so far from company like Gen-Probe Incorporated.
What Percentage of ProciseDx US Patent Applications were Granted?
ProciseDx (Excluding its subsidiaries) has filed 10 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 33.33%.
Below are the key stats of ProciseDx patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for ProciseDx?
Law Firm | Total Applications | Success Rate |
Kilpatrick Townsend & Stockton Llp | 10 | 33.33% |
List of ProciseDx Patents
ProciseDx Patents | Title |
US11119043B2 | Analyzer |
US11119096B2 | Universal Assay For Determining The Quantity Of Therapeutic Monoclonal Antibodies And Their Corresponding Anti-Drug-Antibodies In Samples |
US11085931B2 | Universal Assay For Determining The Quantity Of Tnfα Inhibitory Drugs And Their Corresponding Anti-Drug-Antibodies |
US20240012007A9 | Assay Method For The Detection Of Vcam-1 And Alpha-2-Macroglobulin In Blood |
US20230160906A1 | Detection Of Anti-Tnf Alpha Drug Biologics And Anti-Drug Antibodies |
US20230131780A1 | Methods Of Detecting Antibodies To Sars-Cov-2 |
US20230108128A1 | Predetermined Calibration Curve |
US20220283173A1 | Differential Detection Of Viral And Bacterial Infections |
US20220155230A1 | Light Source Accommodation For Different Sample Matrices |
US20220146501A1 | Assay Methods For The Detection Of Human Serum Albumin, Vitamin D, C-Reactive Protein, And Anti-Transglutaminase Autoantibody |
US20220137035A1 | Detection Of Hemoglobin A1C (Hba1C) In Blood |
US20210405063A1 | Assay Detection Methods For Vcam-1 And Calprotectin |
US20210307729A1 | Fecal Sampler |
EP3752819B1 | Analyzer |
EP3821250B1 | An Assay Method For The Detection Of Vcam-1 And Alpha-2-Macroglobulin In Blood |
EP3990894A1 | Methods For Accommodating For Sample Matrix Effects In Light Measurement Assays |
EP3990922A1 | Detection Of Anti-Tnf Alpha Drug Biologics And Anti-Drug Antibodies |
EP3973290A1 | Assay Methods For The Detection Of Human Serum Albumin, Vitamin D, C-Reactive Protein, And Anti-Transglutaminase Autoantibody |
EP3969906A1 | Assay Detection Methods For Vcam-1 And Calprotectin |
EP3880083A1 | Fecal Sampler |
EP3568398A1 | Cryptate Derivatives And Their Use As Luminescent Lanthanide Complexes |
ES2956109T3 | Analyzer |
US20200222896A1 | Assay Cuvette |
US20190284211A1 | Cryptates And Methods Of Use |
EP4070104A2 | Differential Detection Of Viral And Bacterial Infections |
EP3980779A1 | Detection Of Hemoglobin A1C (Hba1C) In Blood |
EP3752289A1 | Assay Cuvette |
AT1489581T | Test method for detecting Vcam-1 and alpha-2 macroglobulin in blood |
WO2021242725A1 | Predetermined Calibration Curve |
WO2021222533A1 | Methods Of Detecting Antibodies To Sars-Cov-2 |
WO2021113457A3 | Differential Detection Of Viral And Bacterial Infections |
WO2020263450A1 | Detection Of Anti-Tnf Alpha Drug Biologics And Anti-Drug Antibodies |
WO2020264295A1 | Methods For Accommodating For Sample Matrix Effects In Light Measurement Assays |
WO2020247159A1 | Detection Of Hemoglobin A1C (Hba1C) In Blood |
WO2020236528A1 | Assay Methods For The Detection Of Human Serum Albumin, Vitamin D, C-Reactive Protein, And Anti-Transglutaminase Autoantibody |
WO2020232295A1 | An Assay Method For The Detection Of Vcam-1 And Alpha-2-Macroglobulin In Blood |
WO2020232262A1 | Assay Detection Methods For Vcam-1 And Calprotectin |
What are ProciseDx key innovation segments?
What Technologies are Covered by ProciseDx?
The chart below distributes patents filed by ProciseDx